Frickenhausen – Production of the first stem cell burger, which recently hit the headlines throughout the world, also owes its success to high-quality laboratory products from Greiner Bio-One. The technology partner for the diagnostic and pharmaceutical industries contributed premium-grade laboratory materials for the development process.

For the first time, scientists from Maastricht University in the Netherlands have succeeded in cultivating a hamburger in a laboratory from the stem cells of cattle. The stem cells can be extracted from muscle cells, for example. The stem cells from a single cow can be used to produce around 200 million burgers. Industrial production, it is hoped, could act as a significant brake on intensive livestock farming and thus also curb environmental pollution.

Yet as stem cells are particularly sensitive, cultivating them is highly complex. The cells need an ambient temperature of 37 °C and must be protected against bacteria and fungi continuously. That’s why it is all the more important that the laboratory products used such as multiwell plates, cell culture flasks and pipettes from Greiner Bio-One, as utilized for this project, meet the strictest requirements.

“The fact that such an elaborate and complicated project is carried out with our products demonstrates our customer’s confidence in the quality,” explains Managing Director Heinz Schmid. Thanks to its many years of experience as a laboratory product manufacturer, Greiner Bio-One is able to comply with all required product standards and guarantee such compliance. All laboratory materials are available in various sizes and versions. They are versatile and can also be employed for highly complex purposes such as stem cell research.

Greiner Bio-One GmbH – BioScience Division

Greiner Bio-One is specialised in the development, production and distribution of plastic laboratory products. The company is a technology partner for universities, research institutes and the diagnostic, pharmaceutical and biotechnology industries as well.

With the BioScience division, Greiner Bio-One ranks among the leading providers of specialised products for the cultivation and analysis of cell and tissue cultures, as well as microplates for high-throughput screening, allowing industry and research most rapid and efficient drug screening. Additionally Greiner Bio-One develops innovative biochip technologies for genotyping.

Under the management of Georg Heftberger, Rainer Perneker and Heinz Schmid, the German headquarters of the BioScience division in Frickenhausen (Baden-Württemberg) controls the whole research and development activities in the product ranges Cell Culture, High-Throughput Screening, Biochips and OEM.

Greiner Bio-One GmbH is a division of Greiner Bio-One International AG, based in Kremsmuenster (Austria). Today Greiner Bio-One International AG generates a turnover of 364 million euros. It has over 1,700 employees and operates globally with 24 subsidiaries and numerous distributors in more than 100 countries.

For further information please contact:

Greiner Bio-One GmbH Zeeb Kommunikation GmbH

Simone Schafstein & Sylvia Bauer Anja Pätzol

bachstrasse 2 Hohenheimer Strasse 58a

72636 Frickenhausen, Germany 70184 Stuttgart, Germany

Phone: +49 (0) 7022 / 948-0 Phone: +49 (0) 711 60707-19

Fax: +49 (0) 7022 / 948-514 Fax: +49 (0) 711 60707-39

E-mail: marketing@de.gbo.com E-mail: info@zeeb.info